Skip to content

Optimization of Movement Patterns in Elite Volleyball Players

Optimaliseren Van Lichaams- en Bewegingsspecifieke Kenmerken Bij Volleybalspelers Met Het Oog op Het Reduceren Van Blessures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02554461
Enrollment
37
Registered
2015-09-18
Start date
2015-08-31
Completion date
2017-03-31
Last updated
2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optimisation of Performance and Avoidance of Injury

Brief summary

On the basis of clinical and movement analysis records players are informed on what parameters can be optimized in order to improve their performance and avoid injuries

Interventions

OTHERadvise for exercices given by team staff

To respond to questions asked: it is not the investigator who decides on the intervention, but the daily team staff (e.g. trainer, coach, PT,.....). So no predetermined intervention is provided

Sponsors

Prof. Dr. F. Staes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Members of national volleyball team signing informed consent

Exclusion criteria

No specific

Design outcomes

Primary

MeasureTime frameDescription
2D and 3D joint angles of different movements together with kinetics1 daykinematics and kinetics with regard to gait, running, jumping and arm movements. This means for example joint angles (measured by 3D motion analyses data, 2D measurement data) and kinetics (joint moments, pressure plate measurements) Time frames: these data will recorded by one measurement session. For information of clinicaltrials.gov (also other outcome measures): at this point it really is an observational study. It is a kind of service project for an elite athletes team. Advice is provided, but not as is meant within a real clinical trial. It might evolve to such a project, but at this state it is not the case.

Secondary

MeasureTime frameDescription
joint stability1 daynominal scale (good, poor)
joint control1 daynominal scale (good, poor)
prevalence injury past1 dayinterview (frequency/percentage of occurrence)
muscle strength1 dayisokinetic measurements (expressed in Nm)
(segmental) length1 dayMeter
weight1 dayKg
Body mass index1 dayKg/m²
prevalence injury present1 dayinterview (yes/no)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026